Description

Description

Gvia-M XR (50/1000mg) is a combination diabetes medication manufactured by Genix Pharma, containing Sitagliptin together with extended-release Metformin Hydrochloride in a single film-coated tablet. This pack contains 14 tablets and is formulated for individuals living with type 2 diabetes mellitus who require more than one blood-sugar-lowering agent to achieve adequate glycemic control. This particular strength provides a higher dose of extended-release Metformin compared to the 50/500mg variant, and it is typically considered for patients whose blood sugar levels require a more pronounced Metformin component alongside Sitagliptin. The extended-release formulation allows the medicine to be released gradually into the body over a longer period, which is often associated with more convenient once-daily dosing and may help reduce certain digestive side effects compared to immediate-release Metformin. Gvia-M XR is intended for use as part of a broader diabetes management plan that typically also includes dietary control, regular physical activity, and routine blood glucose monitoring, all under the supervision of a qualified physician.

Ingredients

Each Gvia-M XR (50/1000mg) tablet contains Sitagliptin, present as Sitagliptin Phosphate Monohydrate, at a strength of 50mg, along with Metformin Hydrochloride in extended-release form at a strength of 1000mg. The tablet core also typically includes standard pharmaceutical excipients such as binders, fillers, and a specialized extended-release coating that controls the gradual release of Metformin. The exact inactive ingredient list may be confirmed by checking the printed leaflet inside the pack, as formulations can occasionally be refined by the manufacturer.

Dosage Form

Gvia-M XR is supplied as an oral extended-release film-coated tablet. Each box contains 14 tablets, typically arranged in blister strips for protection against moisture and light. The extended-release design allows the tablet to release Metformin slowly over time rather than all at once, which distinguishes it from standard immediate-release combination tablets.

Uses

Gvia-M XR is primarily used to improve blood glucose control in adults diagnosed with type 2 diabetes mellitus. The two components work through different but complementary pathways to achieve this effect. Sitagliptin belongs to a class of medicines known as DPP-4 inhibitors, and it works by increasing the levels of certain natural hormones called incretins, which help the body produce more insulin when blood sugar is high while also reducing the amount of sugar produced by the liver. Metformin, on the other hand, belongs to the biguanide class and works mainly by decreasing glucose production in the liver, reducing intestinal absorption of glucose, and improving the body’s sensitivity to insulin in muscle tissue, with the extended-release formulation providing a steadier effect throughout the day. Together, this combination is generally prescribed for patients whose blood sugar is not adequately controlled on Metformin alone, or as directed by a treating physician based on individual health assessment and the appropriate Metformin strength required.

How to Use

Gvia-M XR should only be taken exactly as prescribed by a doctor. It is generally recommended to take the tablet once daily with the evening meal to support consistent absorption and reduce the likelihood of stomach-related discomfort. The tablet must be swallowed whole with a glass of water and should never be crushed, split, or chewed, as doing so can interfere with the extended-release mechanism and cause the medicine to be released too quickly. Dosage and frequency will vary depending on individual blood sugar levels, kidney function, other medications being taken, and overall health status, so patients should never adjust their dose without medical guidance. Missing a dose should not be compensated for by taking a double dose at the next scheduled time.

Side Effects

As with any medication, Gvia-M XR may cause side effects in some individuals, though not everyone will experience them. Commonly reported effects may include nausea, mild stomach upset, diarrhea, reduced appetite, or a metallic taste in the mouth, particularly when treatment is first started. Less commonly, some patients may experience headache, upper respiratory tract symptoms, or joint discomfort. In rare cases, more serious effects such as signs of low blood sugar, especially when combined with other diabetes medicines, unusual muscle pain, or symptoms of pancreatitis marked by persistent abdominal pain may occur and should be reported to a doctor immediately. Some patients may also notice what appears to be a tablet remnant in their stool, which is generally harmless and simply reflects the empty shell of the extended-release tablet after the medicine has been absorbed. This information is not exhaustive, and patients should read the enclosed leaflet or consult their physician or pharmacist for complete safety information.

Pregnancy & Breastfeeding

The safety of Gvia-M XR during pregnancy and breastfeeding has not been firmly established for this specific combination. Diabetes management during pregnancy typically requires a different, carefully individualized treatment approach, and this medicine should not be used by pregnant women or those planning pregnancy unless specifically advised by a treating physician. Similarly, women who are breastfeeding should consult their doctor before use, as it is not fully known whether these components pass into breast milk. Medical supervision is essential in both situations.

Storage Instructions

Gvia-M XR tablets should be stored at room temperature, generally below 30°C, away from direct sunlight, excessive heat, and moisture. The medicine should be kept in its original blister pack until the time of use, and it should be stored out of reach of children. The tablets should not be used beyond the expiry date printed on the packaging, and any unused or expired medication should be disposed of responsibly rather than discarded in regular household waste.

FAQS

Q: Can Gvia-M XR be crushed or split for easier swallowing?
No, the tablet must be swallowed whole, as crushing or splitting it can interfere with the extended-release mechanism and affect how the medicine works.

Q: Is Gvia-M XR suitable for type 1 diabetes?
No, this combination is intended for type 2 diabetes management only.

Q: How is the 50/1000mg strength different from the 50/500mg strength?
The Sitagliptin dose remains the same at 50mg, while the extended-release Metformin component is higher at 1000mg, which may be prescribed based on individual blood sugar control needs as determined by a doctor.

Q: Does Gvia-M XR interact with other medicines?
Yes, it may interact with certain other drugs. Always inform your doctor of all medications and supplements you are currently taking.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.